Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: GroupAssignment: Quadpill vs. Candesartan - XML Representation

Raw xml | Download

<EvidenceVariable xmlns="http://hl7.org/fhir">
  <id value="375183"/>
  <meta>
    <versionId value="4"/>
    <lastUpdated value="2025-06-10T18:29:54.548Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"/>
  </meta>
  <text>
    <status value="empty"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
  </text>
  <url value="https://fevir.net/resources/EvidenceVariable/375183"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="urn:ietf:rfc:3986"/>
    <value value="https://fevir.net/FOI/375183"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <name value="GroupAssignment_Quadpill_vs_Candesartan"/>
  <title value="GroupAssignment: Quadpill vs. Candesartan"/>
  <citeAs
          value="GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375183. Revised 2025-06-10. Available at: https://fevir.net/resources/EvidenceVariable/375183. Computable resource at: https://fevir.net/resources/EvidenceVariable/375183#json."/>
  <status value="active"/>
  <author>
    <name value="Brian S. Alper, MD, MSPH"/>
  </author>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description value="Example of GroupAssignment Profile"/>
  <useContext>
    <code>
      <system value="https://fevir.net/resources/CodeSystem/179423"/>
      <code value="evidence-communication"/>
      <display value="Evidence Communication"/>
    </code>
    <valueCodeableConcept>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="GroupAssignment"/>
        <display value="GroupAssignment"/>
      </coding>
    </valueCodeableConcept>
  </useContext>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <definition>
    <concept>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="defined-in-handling-and-category"/>
        <display value="Defined in handling and category elements"/>
      </coding>
    </concept>
  </definition>
  <handling value="dichotomous"/>
  <category>
    <name value="Quadpill once daily"/>
    <valueReference>🔗 
      <reference value="Group/375175"/>
      <type value="Group"/>
      <display value="QUARTET USA Trial Quadpill group"/>
    </valueReference>
  </category>
  <category>
    <name value="Candesartan 8 mg once daily"/>
    <valueReference>🔗 
      <reference value="Group/375182"/>
      <type value="Group"/>
      <display value="QUARTET USA Trial Control Group"/>
    </valueReference>
  </category>
</EvidenceVariable>